Select Medical Holdings stock (US81642T1007): buyout offer puts spotlight on valuation and strategy
Select Medical Holdings has agreed to be taken private in a cash deal for $16.50 per share, led by members of its own leadership team. A law firm is investigating whether shareholders are receiving a fair price, adding uncertainty but also investor interest. This transaction highlights the continued strong interest in specialized US healthcare assets and raises questions about valuation, transparency, and the potential for revised terms.
SELECT MEDICAL HOLDINGS CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Select Medical Holdings Corporation's Directors and Officers for Breach of Fiduciary Duties - SEM
Scott+Scott Attorneys at Law LLP has initiated an investigation into Select Medical Holdings Corporation (NYSE: SEM) regarding a proposed buyout of the company. The firm is investigating whether the company's directors and officers breached their fiduciary duties to shareholders by approving a buyout offer of $16.50 per share, which is considered inadequate. Shareholders are encouraged to contact attorney Joseph A. Pettigrew for more information on the investigation.
Select Medical, Carilion Clinic to Build Rehab Hospital in Virginia
Select Medical Holdings Corporation and Carilion Clinic are collaborating to construct a new rehabilitation hospital in Virginia. This announcement highlights Select Medical's ongoing expansion in the healthcare facilities sector, specifically in rehabilitation services. The article also provides recent stock performance and analyst ratings for Select Medical.
New 50-bed rehab hospital coming to Roanoke as 34-bed unit closes
Select Medical (SEM) and Carilion Clinic have formed a joint venture to build and operate a new 50-bed inpatient rehabilitation hospital in Roanoke, Virginia. This new state-of-the-art facility, where Select Medical will be the majority owner and manager, is scheduled to begin construction in spring 2026 and open in spring/summer 2028. Upon its opening, Carilion Roanoke Community Hospital's existing 34-bed acute rehabilitation unit will close.
Halper Sadeh LLC is Investigating Whether SEM, WSR, INM, GDOT are Obtaining Fair Deals for their Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating Select Medical Holdings Corporation (SEM), Whitestone REIT (WSR), InMed Pharmaceuticals, Inc. (INM), and Green Dot Corporation (GDOT) for potential violations of federal securities laws and breaches of fiduciary duties. The firm is examining whether the proposed transactions for these companies ensure fair deals for their shareholders, suspecting insiders may receive disproportionate financial benefits or that terms could limit superior offers. Shareholders are encouraged to contact Halper Sadeh LLC to discuss their rights and options.
Select Medical (SEM) to be taken private at $16.50 per share by WCAS-led group
Select Medical Holdings Corporation (SEM) will be taken private at $16.50 per share by a group led by Welsh, Carson, Anderson & Stowe (WCAS), including Robert A. Ortenzio and Martin F. Jackson. The deal, which offers an 18% premium over the unaffected price, requires stockholder approval, including a majority vote excluding shares held by Parent Affiliated Stockholders. Certain executives and directors will rollover their shares into the new private entity and will receive severance benefits upon termination.
Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders?
Halper Sadeh LLC, an investor rights law firm, is investigating several companies—Select Medical Holdings Corporation (SEM), UniFirst Corporation (UNF), Centessa Pharmaceuticals plc (CNTA), and Assertio Holdings, Inc. (ASRT)—for potential violations of federal securities laws and breaches of fiduciary duties. The investigations concern proposed sales and acquisitions that may not offer fair deals to ordinary shareholders due to potential financial benefits for insiders and terms that could limit superior competing offers. Halper Sadeh LLC encourages shareholders to contact them to discuss their legal rights and options.
Dana Investment Advisors Inc. Buys 153,924 Shares of Select Medical Holdings Corporation $SEM
Dana Investment Advisors Inc. increased its stake in Select Medical Holdings Corporation (SEM) by 29.3% in the fourth quarter, purchasing 153,924 shares to bring its total holding to 678,545 shares valued at approximately $10.1 million. Despite high institutional ownership (89.48%), analysts maintain a cautious "Hold" consensus rating with an average target price of $15.50. The company recently missed EPS expectations but slightly beat revenue estimates, declared a quarterly dividend of $0.0625, and initiated a $1.00 billion stock buyback plan.
Glazer Capital reports 5.21% stake in Select Medical (SEM)
Glazer Capital, LLC and Paul J. Glazer have reported a beneficial ownership of 6,465,826 shares in Select Medical Holdings Corporation (SEM), representing 5.21% of the class as of May 7, 2026. This ownership, disclosed in a Schedule 13G filing, indicates shared voting and dispositive power over the shares and is described as a passive investment. The filing clarifies that this disclosure is made by the investment manager and its managing member, with no assertion of additional transactions or changes beyond the ownership itself.
Select Medical Holdings stock (US81642T1007): Mizuho Downgrades Rating, Cuts Target to $16.50
Mizuho Securities has downgraded Select Medical Holdings (NYSE: SEM) and cut its price target to $16.50, citing concerns over the healthcare provider's future outlook and pressures in the post-acute care sector. This downgrade comes amidst reports of a potential buyout investigation into the company. Select Medical Holdings, a significant player in critical illness recovery and rehabilitation services, faces sector challenges like labor shortages and reimbursement pressures despite growing demand from an aging U.S. population.
SELECT MEDICAL HOLDINGS CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Select Medical Holdings Corporation’s Directors and Officers for Breach of Fiduciary Duties – SEM
Scott+Scott Attorneys at Law LLP has initiated an investigation into Select Medical Holdings Corporation (NYSE: SEM) and its directors and officers. The investigation concerns whether the proposed buyout of Select Medical Holdings for $16.50 per share, led by its CEO, Executive Vice President, and private equity firm Welsh, Carson, Anderson & Stowe, constitutes inadequate consideration and a breach of fiduciary duties to shareholders. Shareholders of Select Medical Holdings are encouraged to contact attorney Joseph A. Pettigrew to discuss their rights.
Mizuho Downgrades Select Medical to Neutral From Outperform, Adjusts PT to $16.50 From $17
Mizuho has downgraded Select Medical Holdings Corporation (SEM) from an "Outperform" rating to "Neutral." The firm also adjusted its price target for SEM, lowering it to $16.50 from the previous $17.00. This news follows a recent period where other financial institutions such as Deutsche Bank and RBC also downgraded Select Medical.
Is It Time To Reassess Select Medical Holdings (SEM) After Recent 2026 Guidance Update?
This article evaluates Select Medical Holdings (SEM) after its recent 2026 guidance update, utilizing two primary valuation methods: Discounted Cash Flow (DCF) and Price-to-Earnings (P/E) ratios. The DCF model suggests SEM is overvalued by 28.2% at its current share price of $16.45, estimating an intrinsic value of $12.83 per share. Conversely, the P/E ratio analysis, comparing SEM's 15.68x P/E to an industry average of 23.17x and a "Fair Ratio" of 19.63x, indicates the stock may be undervalued.
Select Medical Cut to Neutral From Outperform by Mizuho
Mizuho has downgraded Select Medical Holdings Corporation (SEM) from "Outperform" to "Neutral." This rating change suggests a revised outlook on the company's stock performance by the analyst firm.
Vanguard Group Inc. Sells 94,378 Shares of Select Medical Holdings Corporation $SEM
Vanguard Group Inc. reduced its stake in Select Medical Holdings Corporation by selling 94,378 shares in the fourth quarter, though it still holds a significant 10.08% of the company. Select Medical reported mixed Q4 earnings with lower-than-anticipated EPS but slightly higher revenue. The company announced a quarterly dividend, a new $1 billion share repurchase program, and currently holds a consensus "Hold" rating from analysts.
Select Medical Holdings (NYSE:SEM) - Stock Analysis
Select Medical Holdings (NYSE:SEM) is undergoing a take-private deal by a consortium led by Executive Chairman Robert A. Ortenzio for $16-$16.50 per share, with closing expected mid-2026. The company reported mixed Q1 2026 results, with increased revenue and inpatient rehabilitation activity but declining adjusted EBITDA and EPS missing estimates. Shareholders are advised to consider the limited upside due to the fixed cash price and potential regulatory hurdles.
Select Medical Holdings Corporation $SEM Shares Purchased by Western Standard LLC
Western Standard LLC significantly increased its stake in Select Medical Holdings Corporation (NYSE:SEM) by 95.6% in Q4, making it their largest holding. Select Medical's board authorized a $1 billion share buyback and declared a quarterly dividend, despite missing EPS estimates in its latest quarterly report. Analysts currently hold a "Hold" rating on SEM with an average target price of $15.63.
Select Medical Holdings Corporation Announces Pricing of Offering of 6.250% Senior Notes due 2032 by Select Medical Corporation
Select Medical Holdings Corporation announced the pricing of an offering of 6.250% Senior Notes due 2032 by its subsidiary, Select Medical Corporation. Quantisnow Plus members were alerted to this press release immediately upon publication, highlighting the platform's real-time market intelligence for investors. The announcement is a financial update regarding the company's debt offering.
Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches in the Select Medical Take-Private Transaction
Johnson Fistel, PLLP has initiated an investigation into whether the board of Select Medical Holdings Corporation (NYSE: SEM) breached its fiduciary duties regarding the proposed take-private transaction. The investigation focuses on whether the board conducted a fair process to maximize shareholder value and if minority shareholders are receiving fair consideration for their shares in the $16.50 per share cash deal. The transaction involves a consortium led by executives and Welsh, Carson, Anderson & Stowe acquiring all outstanding shares not already owned by them, with certain insiders rolling over their equity instead of taking cash.
Select Medical Q1 Earnings Miss Estimates on Higher Expenses
Select Medical Holdings Corporation reported first-quarter 2026 adjusted EPS of 36 cents, missing estimates by 16.3% due to higher expenses and a decline in patient days in the Critical Illness Recovery Hospital segment. Despite this, net operating revenues increased 5% year-over-year, beating the consensus, largely driven by strong performance in the Rehabilitation Hospital segment. The company reaffirmed its 2026 guidance for revenues, adjusted EBITDA, and EPS.
Transcript: Select Medical Hldgs Q1 2026 Earnings Conference Call
Select Medical Holdings (SEM) reported its Q1 2026 financial results, including a 5% increase in total revenue but a 6.5% decline in adjusted EBITDA. The company also announced a take-private transaction at $16.50 per share, expected to close mid-2026, and outlined plans for expanding its inpatient rehabilitation services by adding 275 beds by 2027. Management discussed the impact of increased Medicare Advantage denials on long-term acute care hospitals, while maintaining its unchanged full-year 2026 guidance for revenue and adjusted EBITDA.
Select Medical Holdings Corporation (NYSE:SEM) Q1 2026 Earnings Call Transcript
Select Medical Holdings Corporation (NYSE:SEM) held its Q1 2026 earnings call, announcing an agreement to be acquired by a consortium led by its Executive Chairman for $16.50 per share in cash, with the transaction expected to close in mid-2026. The company reported a 5% increase in total revenue but a 6.5% decline in Adjusted EBITDA year-over-year. Management also discussed expansion plans for its inpatient rehabilitation business, regulatory proposals for 2027 affecting payment rates, and challenges with Medicare Advantage denials impacting critical illness recovery hospitals.
Select Medical (SEM) vice chair surrenders shares for tax withholding
Select Medical Holdings Corp vice chairman David S. Chernow surrendered 22,586 shares of Common Stock on April 30, 2026. This transaction was to satisfy a tax withholding obligation related to the vesting of restricted stock, with the shares valued at $16.41 each. Following this, Chernow directly holds 870,244 shares.
Buyout deal and Q1 results shape Select Medical (NYSE: SEM) 2026 outlook
Select Medical Holdings Corporation (NYSE: SEM) reported mixed Q1 2026 results with a 5.0% revenue increase to $1,421.5 million but a decline in net income and EPS. The company maintained its full-year 2026 outlook and declared a quarterly cash dividend while awaiting regulatory and shareholder approvals for its acquisition by a buyer group for $16.50 per share.
Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2026 and Cash Dividend
Select Medical Holdings Corporation announced its first-quarter 2026 results, with revenue increasing by 5.0% to $1,421.5 million, though net income and Adjusted EBITDA saw declines compared to the prior year. The company also declared a cash dividend of $0.0625 per share and reiterated its full-year 2026 business outlook. Additionally, Select Medical provided updates on its pending merger agreement, which is expected to close in mid-2026.
Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches in the Select Medical Take-Private Transaction
Johnson Fistel, PLLP has initiated an investigation into potential breaches of fiduciary duties by the board members of Select Medical Holdings Corporation (NYSE: SEM) concerning its proposed sale. The firm is examining whether the board conducted a fair process to maximize shareholder value and if minority shareholders are receiving fair consideration for their shares in the take-private transaction. Shareholders can join the investigation if they believe the $16.50 per share offer undervalues their investment.
Select Medical Holdings Corporation Declares Quarterly Dividend of $0.06 (NYSE:SEM)
Select Medical Holdings Corporation (NYSE:SEM) declared a quarterly dividend of $0.0625 per share, representing an annualized dividend of $0.25 and a yield of 1.5%. The dividend will be paid on May 28th to shareholders of record on May 14th. The company recently reported Q1 EPS of $0.36, missing consensus estimates, on revenue of $1.42 billion, a 5.0% year-over-year increase.
Select Medical keeps forecast as $16.50-a-share buyout heads to vote
Select Medical (NYSE: SEM) reported Q1 2026 results, with revenue rising 5% to $1,421.5 million, though income from operations and net income decreased. The company declared a cash dividend of $0.0625 per share and reiterated its full-year 2026 business outlook. A proposed merger for $16.50 per share in cash is pending regulatory and shareholder approvals, expected to close in mid-2026, after which the company's shares will be delisted.
162,000 Shares in Select Medical Holdings Corporation $SEM Acquired by Levin Capital Strategies L.P.
Levin Capital Strategies L.P. acquired a new position in Select Medical Holdings Corporation, purchasing 162,000 shares valued at approximately $2.41 million. This transaction highlights significant institutional interest, with such investors now owning nearly 89.48% of the stock. Select Medical recently reported Q4 results, missing EPS estimates but beating revenue expectations, and announced a new $1.00 billion share buyback program and a quarterly dividend.
SELECT MEDICAL HOLDINGS CORPORATION INVESTOR ALERT: Scott+Scott A
Scott+Scott Attorneys at Law LLP has initiated an investigation into Select Medical Holdings Corporation (NYSE: SEM) regarding a proposed buyout. The investigation concerns whether the company's officers and directors breached their fiduciary duties to shareholders by approving a buyout for potentially inadequate consideration of $16.50 per share. Shareholders are encouraged to contact attorney Joe Pettigrew to discuss their rights and the ongoing investigation.
Director William H. Frist gets SEM (NYSE: SEM) stock grant worth $18,000
Select Medical Holdings director William H. Frist received a grant of 1,094 restricted shares of common stock valued at $18,000, in lieu of a quarterly cash retainer. The shares, valued at $16.45 each, were issued under the company's 2020 Equity Incentive Plan. Following this transaction, Frist directly holds 306,266 shares of Select Medical Holdings Common Stock.
SELECT MEDICAL HOLDINGS CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Select Medical Holdings Corporation’s Directors and Officers for Breach of Fiduciary Duties – SEM
Scott+Scott Attorneys at Law LLP has initiated an investigation into Select Medical Holdings Corporation (NYSE: SEM) regarding a potential breach of fiduciary duties by its officers and directors. The investigation stems from a proposed buyout of the company by a group led by its CEO, founder, and a private equity firm for $16.50 per share, which Scott+Scott believes may constitute inadequate consideration for shareholders. The law firm is seeking shareholders of Select Medical Holdings common stock to join their investigation.
Vanguard (NYSE: SEM) reports 6.76M shares; 5.45% stake disclosed
Vanguard Portfolio Management has reported a beneficial ownership of 6,764,889 shares of Select Medical Holdings Corp Common Stock, representing a 5.45% stake as of March 31, 2026. The Schedule 13G filing indicates Vanguard has sole voting power for 41,332 shares and sole dispositive power for all 6,764,889 shares. Ashley Grim, Head of Global Fund Administration, signed the report on April 29, 2026.
After antitrust wait ends, Select Medical still needs shareholder approval
Select Medical (NYSE: SEM) announced that the Hart-Scott-Rodino antitrust waiting period for its proposed acquisition by a WCAS XIV subsidiary and a consortium led by Robert A. Ortenzio and Martin F. Jackson expired on April 27, 2026. The merger, expected to close mid-2026, still requires approval from Select Medical shareholders, including a majority of shares not held by the Consortium, and other customary closing conditions. This marks a significant regulatory hurdle cleared, though shareholder vote remains crucial for the transaction's completion.
Select Medical Holdings Corporation (NYSE:SEM) Receives Average Recommendation of "Hold" from Analysts
Select Medical Holdings Corporation (NYSE:SEM) has received an average "Hold" rating from six analysts, with a consensus 12-month price target of $15.63. The company missed Q4 EPS estimates but exceeded revenue expectations, while also approving a significant share repurchase program and maintaining its quarterly dividend. Institutional investors hold a substantial portion of the company's stock.
Select Medical Holdings shareholders approve board changes and proposals at annual meeting
Select Medical Holdings shareholders approved various proposals at their annual meeting, including the election of three Class II directors, a non-binding advisory vote on executive compensation, and the ratification of PricewaterhouseCoopers LLP as their accounting firm. They also approved an amendment to phase out the classified board structure and a proposal giving shareholders the right to call a special meeting at a 25% ownership threshold, while rejecting a 10% threshold. The company is also in the process of being acquired by a consortium led by its executive chairman for an enterprise value of $3.9 billion.
Select Medical Shareholders Back Governance Changes at Annual Meeting
Select Medical (SEM) shareholders, at their annual meeting on April 23, 2026, re-elected directors, approved executive compensation, and ratified PwC as the independent auditor. Key governance changes included phasing out the classified board structure and setting a 25% ownership threshold for calling special meetings, while rejecting a lower 10% threshold. Spark, TipRanks’ AI Analyst, rates SEM as Neutral due to mixed financial performance but notes a positive catalyst from an announced go-private transaction.
Select Medical co-founder proposes to buy all shares, take company private
Select Medical co-founder and Executive Chairman Robert Ortenzio has proposed to acquire all outstanding shares of the company not already owned by him and CEO David Chernow, aiming to take the company private. The offer is for $27.00 per share in cash, representing a 20% premium over the previous day's closing price. A special committee has been formed to evaluate the non-binding proposal.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Select Medical Holdings Corporation ("SEM")
Levi & Korsinsky, LLP has launched an investigation into Select Medical Holdings Corporation ("SEM") regarding potential breaches of fiduciary duty by its Board of Directors. This investigation follows the company's agreement to be acquired by a consortium led by Executive Chairman Robert A. Ortenzio, Senior Executive Vice President Martin F. Jackson, and private equity firm Welsh, Carson, Anderson & Stowe for $16.50 per share. The firm is inviting affected shareholders to learn more about their rights.
Select Medical Holdings Corporation (NYSE:SEM) Short Interest Update
Select Medical Holdings Corporation (NYSE:SEM) saw a significant increase in short interest in March, rising 19.4% to 2,737,454 shares, which represents about 2.6% of the stock. Despite this, institutional ownership remains high at 89.48%, with several hedge funds, including Millennium Management, increasing their stakes. The company announced a $1.00 billion stock repurchase program, signaling management's belief that the stock may be undervalued, and also declared a quarterly dividend of $0.0625 per share.
Are VRE, SEM, TWO Obtaining Fair Deals for their Shareholders?
Halper Sadeh LLC, an investor rights law firm, is investigating Veris Residential, Inc. (VRE), Select Medical Holdings Corporation (SEM), and Two Harbors Investment Corp. (TWO) for potential violations of federal securities laws and breaches of fiduciary duties related to their recent or proposed sales. The firm is concerned that insiders may be receiving substantial financial benefits not available to ordinary shareholders and that the transactions might limit superior competing offers. Shareholders are encouraged to contact Halper Sadeh LLC to discuss their rights and options.
(SEM) Movement as an Input in Quant Signal Sets
This article analyzes Select Medical Holdings Corporation (NYSE: SEM) using AI-generated quant signals. It identifies a current neutral sentiment across all horizons with a mid-channel oscillation pattern in play. The report offers three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, along with specific entry, target, and stop-loss levels.
Select Medical Holdings Corporation to Announce First Quarter 2026 Results on Thursday, April 30, 2026
Select Medical Holdings Corporation (NYSE: SEM) will release its first quarter 2026 financial results on Thursday, April 30, 2026, after market close. The company will host a conference call and webcast on Friday, May 1, 2026, at 9:00 AM ET to discuss these results and provide a business outlook. Investors can access the webcast or pre-register for the call to participate in the question and answer session.
Select Medical sets May 1 call after releasing Q1 results April 30
Select Medical Holdings Corporation (NYSE: SEM) is scheduled to release its first-quarter 2026 financial results after market close on Thursday, April 30, 2026. Following the release, the company will host a webcast conference call on Friday, May 1, 2026, at 9:00 AM ET to discuss the results and business outlook. Investors can access the live webcast or pre-register for a dial-in number to participate in the Q&A session.
Select Medical Holdings Corporation to Announce First Quarter 2026 Results on Thursday, April 30, 2026
Select Medical Holdings Corporation (SEM) is set to announce its First Quarter 2026 results on Thursday, April 30, 2026. This announcement comes via Quantisnow, a real-time market data and news platform that aggregates financial information for investors. The article also provides recent analyst ratings for SEM and lists related press releases and SEC filings.
Analysts Set Select Medical Holdings Corporation Price Target at $15.63
Seven research analysts have issued an average "Hold" recommendation for Select Medical Holdings Corporation (NYSE:SEM), with a 12-month price target of $15.63. The varied ratings and price target reflect the challenges the healthcare provider faces, especially after missing Q4 2025 earnings estimates. Investors will monitor the company's strategic initiatives and financial performance as it navigates the complex healthcare landscape.
Select Medical Holdings Corporation (NYSE:SEM) Receives Consensus Recommendation of "Hold" from Analysts
Select Medical Holdings Corporation (NYSE:SEM) has received a consensus "Hold" recommendation from analysts, with an average 1-year price target of $15.63. The company recently reported mixed quarterly results, missing EPS estimates but exceeding revenue expectations, and announced a new $1.0 billion share repurchase program. Despite recent downgrades from several firms, institutional investors own a significant portion of the stock.
JPMorgan Chase & Co. Raises Stock Holdings in Select Medical Holdings Corporation $SEM
JPMorgan Chase & Co. significantly increased its stake in Select Medical Holdings Corporation by 24.7% in Q3, now owning 554,203 shares valued at approximately $7.12 million. Other institutional investors also adjusted their holdings, with overall institutional ownership at 89.48%. Despite missing Q3 earnings estimates, Select Medical reported strong revenue growth and announced a $1 billion share repurchase program, alongside a quarterly dividend payment.
Tudor Investment Corp ET AL Invests $1.47 Million in Select Medical Holdings Corporation $SEM
Tudor Investment Corp ET AL recently acquired a new stake of 114,204 shares, valued at $1.47 million, in Select Medical Holdings Corporation. This move is part of broader institutional interest, with hedge funds and institutions now owning approximately 89.48% of the company's stock. Select Medical also announced a $1.0 billion share buyback program and a quarterly dividend, despite missing recent EPS estimates but revenue growth.
Short Interest in Select Medical Holdings Corporation (NYSE:SEM) Drops By 24.4%
Short interest in Select Medical Holdings Corporation (NYSE:SEM) decreased significantly by 24.4% in March, totaling 2,292,503 shares as of March 13th. Institutional ownership remains high at nearly 90%, with several hedge funds increasing their stakes. Despite an EPS miss, the company reported revenue growth and has authorized a substantial $1.0 billion stock buyback program.
